You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

648 Results
Regimen
Intent: Palliative
Nov 2024
Regimen
Intent: Palliative
Jul 2023
Regimen
Intent: Palliative
Nov 2024
Regimen
Cancer Type:
Genitourinary, 
Testis
Intent: Palliative
Nov 2024
Regimen
Cancer Type:
Gynecologic, 
Vulva
Intent: Palliative
Nov 2024
Regimen
Cancer Type:
Gynecologic, 
Endometrial
Intent: Palliative
Nov 2024
Regimen
Cancer Type:
Genitourinary, 
Testis
Intent: Palliative
Nov 2024
Regimen
Cancer Type:
Lung, 
Non-Small Cell
Intent: Palliative
Nov 2024
Regimen
Cancer Type:
Lung, 
Non-Small Cell
Intent: Palliative
Nov 2024
Regimen
Cancer Type:
Endocrine, 
Thyroid
Intent: Palliative
Nov 2024
Regimen
Cancer Type:
Gastrointestinal, 
Hepatobiliary / Liver / Bile Duct
Intent: Palliative
Funding:
New Drug Funding Program
    Durvalumab - Locally Advanced Unresectable or Metastatic Biliary Tract Cancer
New Drug Funding Program
    Durvalumab in combination with Tremelimumab - Previously Untreated Unresectable or Metastatic Hepatocellular Carcinoma (HCC)
Apr 2024
Regimen
Intent: Palliative
Mar 2025

Pages